<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02511275</url>
  </required_header>
  <id_info>
    <org_study_id>1308142</org_study_id>
    <secondary_id>2014-A00098-39</secondary_id>
    <nct_id>NCT02511275</nct_id>
  </id_info>
  <brief_title>Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique</brief_title>
  <acronym>NECPAR</acronym>
  <official_title>Assessment of Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique: NECPAR Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital of Saint-Etienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery plays a central role in kidney cancer management being the only therapy that offers&#xD;
      the possibility of healing the patients. Currently, the partial nephrectomy is a standard&#xD;
      technique because it meets the principle of nephron sparing surgery. A partial nephrectomy&#xD;
      requires a control of the renal blood flow using a clamp, which can be parenchymal or&#xD;
      vascular (pedicular). In France, most of the centers use pedicular clamping. It is well&#xD;
      established that this technique results in warm ischemia of the entire healthy parenchyma and&#xD;
      can lead to permanent kidney damages. Currently, no study evaluated the impact of parenchymal&#xD;
      clamping on the healthy parenchyma.&#xD;
&#xD;
      The aim of the investigators study is to evaluate the nephrotoxicity of the healthy&#xD;
      parenchyma due to parenchymal clamping during partial nephrectomy. This assessment will be&#xD;
      done through a microdialysis technique. The microdialysis probe is directly implanted in the&#xD;
      healthy unclamped parenchyma and will allow us to measure in real time, during the surgery,&#xD;
      the biological changes related to anaerobic metabolism of renal interstitial space. All those&#xD;
      measures will be completed by urinary and plasmatic assessments. Oxidative stress will be&#xD;
      assessed using four markers of tubular viability : Interleukin 18 (IL18), Kidney Injury&#xD;
      Molecule-1 (KIM-1), Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cystatin C and four&#xD;
      parameters of anaerobic metabolism : lactate, pyruvate, glycerol and glucose.&#xD;
&#xD;
      This is a prospective pilot study limited to 10 patients included over 12 months. Depending&#xD;
      on the results, it will be further developed by a second study comparing parenchymal with&#xD;
      pedicle clamping.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    this type of surgery is now performed with a surgical robot that no longer allows the&#xD;
    realization of microdialysis&#xD;
  </why_stopped>
  <start_date type="Actual">February 3, 2015</start_date>
  <completion_date type="Actual">March 30, 2015</completion_date>
  <primary_completion_date type="Actual">March 10, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average interstitial lactate concentrations (peak lactate and lactate/pyruvate ratio)</measure>
    <time_frame>every 10 minutes unitl the end of clamping</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interstitial concentrations of lactate, pyruvate, lactate/pyruvate ratio, glycerol concentration (marker of impaired cellular membrane) and glucose concentration</measure>
    <time_frame>every 10 minutes until the end of clamping then every 300 minutes until the third hour of no-clamping</time_frame>
    <description>composite measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood and urine concentration of Interleukin 18 (IL18), le Kidney Injury Molecule-1 (KIM-1), le Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C</measure>
    <time_frame>1 hour before clamping, then Hour +2, Hour +6, Hour +12, Hour +24, Hour +36 ; Hour 0 corresponding to the timing of clamping</time_frame>
    <description>composite measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative creatinine</measure>
    <time_frame>inclusion day and at 2 months postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Nephrectomy</condition>
  <condition>Kidney Cancer</condition>
  <condition>Microdialysis</condition>
  <arm_group>
    <arm_group_label>renal microdialysis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient with renal microdialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Renal microdialysis</intervention_name>
    <description>Renal microdialysis is an innovative and promising technique in the monitoring of renal ischemia. Its sterile nature enables intraoperative use to give us real-time reflection of the in situ metabolism. In Patients who participated in clinical research with this microinvasive technique, no complications including bleeding has been reported.</description>
    <arm_group_label>renal microdialysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients referred to the urological surgery department with an indication of partial&#xD;
             nephrectomy&#xD;
&#xD;
          -  Patients with a renal lesion classified T1 (â‰¤7cm) or for T2 eligible to a partial&#xD;
             nephrectomy and having an possibility to benefit from a parenchymal clamping (decided&#xD;
             on preoperative imaging)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with a chronic kidney disease (functional or structural renal abnormality&#xD;
             evolving for more than three months and Glomerular Filtration Rate &lt;60 ml/min)&#xD;
&#xD;
          -  Patient carrying a renal lesion classified T1 but too close to the renal pedicle or&#xD;
             not accessible for a parenchymal clamping&#xD;
&#xD;
          -  Patients in whom tumor removal requires ice cooling or kidney pedicular clamping&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas MOTTET, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chu de Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>February 20, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>parenchymal clamping</keyword>
  <keyword>microdialysis technique</keyword>
  <keyword>partial nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

